On this page: Contraceptives | MAiD | Mifegymiso | Opioid agonist treatment (OAT) | Paxlovid | Tecovirimat | Plan Z formulary
Plan Z (Assurance) provides full coverage of any included product for any eligible beneficiary. The Full Payment Policy applies to products on Plan Z, other than those identified as partial benefits.
Exceptional Plan Z coverage is available for some products, for people who are not enrolled in MSP.
Plan Z fully covers many contraceptives for B.C. residents enrolled in MSP.
These include oral contraceptives; intrauterine devices (IUDs); an implant; an injection; and emergency oral contraceptives. Products must be entered in PharmaNet by a pharmacist to be covered.
View list of covered contraceptives and PINs at Contraceptives – Information for health professionals.
Exceptional Plan Z coverage of contraceptives is available to B.C. residents who have completed both steps of MSP enrolment but are still in the wait period/not yet actively enrolled.
The pharmacist must:
If patient is eligible:
If patient is not eligible:
Plan Z fully covers MAiD for B.C. residents enrolled in MSP.
For non-PharmaCare-specific information, see Medical Assistance in Dying Information for Health Care Providers. Note that pharmacists must submit the MAiD Dispensing Record (Pharmacist) (PDF, 707KB).
View MAiD-specific PINs.
Exceptional Plan Z coverage for MAiD is available to patients in B.C. who:
The pharmacist contacts the PharmaCare Help Desk and provides:
The pharmacist confirms:
If patient is eligible:
If patient is not eligible:
Plan Z fully covers Mifegymiso for B.C. residents enrolled in MSP.
View Mifegymiso DIN and procedures.
Exceptional Plan Z coverage for Mifegymiso is available to patients in B.C. who have completed both steps of MSP enrolment but are still in the wait period/not yet actively enrolled.
The pharmacist must:
If patient is eligible:
If patient is not eligible:
DIN | 02444038 |
Strength / form | 200 / 0.2 mg tablet |
Drug cost | $324.00 |
Plan | Z and Exceptional Plan Z |
Plan Z covers opioid agonist treatment (OAT) for B.C. residents enrolled in MSP.
OAT regular benefit products are covered under 100% coverage plans B, C, G, as well as Z.
OAT non-benefit products may be considered for exceptional, last-resort coverage with a Special Authority application under plans C, G, W, as well as Z.
Visit OAT PINs and DINs
To ensure continuity of care and harm reduction, exceptional Plan Z coverage is available for OAT for B.C. residents who:
Exceptional coverage can be initiated in two ways: by a prescriber or pharmacist:
1. The prescriber or pharmacist faxes the completed Application for Exceptional Plan Z Coverage for OAT (PDF) to HIBC.
2. The prescriber or pharmacist contacts the PharmaCare Help Desk and provides the following:
The pharmacist or prescriber will confirm:
HIBC will complete the application for exceptional Plan Z for OAT coverage and send it to Special Authority.
If patient is eligible:
Plan Z fully covers Paxlovid for B.C. residents enrolled in MSP. Exceptional Plan Z coverage is not available for Paxlovid.
For more information, please refer to Paxlovid – information for health professionals and Paxlovid for B.C. residents
Refer to guidance for the treatment of monkeypox (PDF, 304KB) for process and procedures of oral tecovirimat (TPOXX™).
For ambulatory patients, tecovirimat must be dispensed by the Product Distribution Centre and documented in PharmaNet.
Plan Z coverage is available for out-of-province patients, or for those in the MSP coverage wait period.
To apply, the prescriber or pharmacist contacts the PharmaCare Help Desk and provides the following:
The pharmacist or prescriber will confirm:
The table below lists Plan Z benefits. This list is for general reference only. It may not reflect the most recent changes to the Plan Z formulary. You can also use the PharmaCare Formulary Search — click on "Assurance" under Select PharmaCare Plan or search by drug name or DIN.
Drugs and services covered by Plan Z | Condition/procedure |
---|---|
contraceptives – refer to the list of covered contraceptives | all indications |
nirmatrelvir/ritonavir (Paxlovid) | COVID-19 |
mifepristone/misoprostol (Mifegymiso) | medical abortion |
bupivicaine | MAiD |
clinical service fee for MAiD iv kit | MAiD |
clinical service fee for MAiD oral kit | MAiD |
haloperidol | MAiD |
lidocaine | MAiD |
lorazepam | MAiD |
metoclopramide | MAiD |
midazolam | MAiD |
non-standard MAiD product | MAiD |
ondansetron | MAiD |
opioid agonist treatment (OAT) – refer to OAT PINs and DINs web page | OAT |
pb+chlorhyd+ms oral cpd susp | MAiD |
phenobarbital sodium | MAiD |
propofol | MAiD |
rocuronium bromide | MAiD |
secobarbital compound suspension | MAiD |
sodium chloride | MAiD |
tecovirimat | mpox |
There are two steps of enrolling in MSP:
Active coverage starts once these steps are complete and the B.C. resident has completed the wait period consisting of the balance of the month in which residence in B.C. is established, plus two months. The wait period starts when residence in B.C. is established. For example, if someone enrols after the end of their wait period, their MSP enrolment will be active as soon as they complete both steps.